BOEHRINGER INGELHEIM INTERNATIONAL GMBH

Company Overview

Boehringer Ingelheim International GmbH is a pharmaceutical company that develops, manufactures, and markets pharmaceuticals, parasiticides, vaccines, and therapeutics for unmet medical needs. It offers an array of products, including human diseases, animal health care products, and biopharmaceuticals. The company’s products are used for the treatment of central nervous system disorders, cardiometabolic diseases, respiratory diseases, cancer, immunology, and retinal diseases, among others. It also offers animal healthcare products for swine, ruminants, poultry, horses, and pets.

The company provides its business offerings through three business segments, namely human pharma, animal health, and others. Contract manufacturing is provided under the human pharma segment. Boehringer Ingelheim Biopharma Contract Manufacturing is now offered by its new brand, Boehringer Ingelheim BioXcellence. BioXcellence offers tailor-made contract development and manufacturing services to the biopharmaceutical industry, providing the entire production technology chain.

Financial Highlights (FY 2023)

Company's Business Segments

• Human Pharma : This segment focuses on cardiovascular and metabolic diseases, respiratory diseases, oncology, mental health, immunology, and retinal diseases.
• Animal Health : The segment portfolio includes products for pets, horses, swine, ruminants, and poultry.